February 2017, London– Aspirico is delighted to announce that it has been shortlisted as one of the finalists for: “Technology Provider of the Year” as part of the prestigious annual Health Investor awards for 2017. Run by Health Investor Magazine, a publication for professionals advising, investing or operating within the health sector, the Health Investor Awards promote excellence and recognise achievement in care.
Health Investor stated that entries were pouring in for this year’s allocades and Aspirico has been shortlisted with five other suppliers who have demonstrated excellence in technology services provision. Declan Kelly, CEO of Aspirico comments: “The Aspirico entry was based on our innovative approach to person centred care which is enabled through our flagship “iplanit” solution suite. A growing list of leading providers within the disability, mental health and vulnerable people sectors are now using iplanit to support tens of thousands of individuals on a daily basis.”
iplanit is a leading case management solution for long term care and disability and has been implemented over 80 times with national and regional service providers right across the UK, Ireland, Australia and New Zealand to support quality, evidence value, drive inclusion, demonstrate compliance, manage risk and help providers transform paper based service delivery processes.
The shortlisted finalists will now be appraised by an independent judging panel and the winners will be announced at the award event on June 1st at the Grosvenor House Hotel. To view the all the shortlisted finalists for this year’s Health Investor awards, click here.